Article Text
Statistics from Altmetric.com
In healthy adults, 70%–80% of our vital capacity can be exhaled in a single second when measured by spirometry. This is made possible by the combination of a highly elastic lung, a low-resistance airway tree and recruitable respiratory muscles. Reduced spirometric values do not necessarily indicate disease, however, since forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and the ratio of FEV1/FVC all decrease as part of normal ageing. Much of lung function is determined by genetics: approximately 40% of lung function can be explained by familial heritability,1 and genome-wide association studies have identified hundreds of genetic variants associated with lung function that, when combined, account for around 6%–12% of this heritability.2 Understanding the genetic control of lung function can give vital insights into the nature of disease and ultimately help us develop preventative treatments.
Mendelian randomisation (MR) is a statistical construct that exploits the relationship between genetic variants and biological features to identify causal associations. In what is known as instrumental variable analysis, the effect of a genetic variant on an exposure (eg, a blood protein) and an outcome (eg, a phenotype or disease) is used to determine the effect of the exposure on the outcome. The ‘randomisation’ element comes from the random allocation of alleles during meiosis: this allows comparison between two groups who differ only by the level of the exposure—akin to treatment arms in a randomised controlled trial—and hence a causal inference can be made. For an easy-to-understand description of …
Footnotes
Twitter @SteveMilne101
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests SM has received research funding from Michael Smith Health Research BC and Mitacs; honoraria from Chiesi Australia, The Limbic and Research Review Australia; and travel support from Sanofi Australia. He is a member of the Executive of the Thoracic Society of Australia and New Zealand (NSW/ACT branch).
Provenance and peer review Commissioned; internally peer reviewed.